Erythropoietin is a hormone released from the kidneys. Erythropoietin protein is responsible for the development of red blood cells (RBCs) in the body. Increase in the number of RBCs raises the level of hemoglobin in the blood, which is the substance responsible for transport of oxygen to every part of the body. Epoetin beta is one of the three erythropoiesis-stimulating agents available in the epoetin beta therapeutics market. It is used for the treatment of anemia in patients with severe kidney disease. Epoetin beta is given in combination with methoxy polyethylene glycol. One of the most common complications of chronic kidney disease is anemia. Its rate of prevalence with CKD is twice than the prevalence rate in the general population. Also, the rate of prevalence of anemia increased rapidly from stage 1 (8.4%) to stage 5 (53.4%) of CKD.

The epoetin beta therapeutics market is expected to expand rapidly during the forecast period, owing to factors such as increase in the prevalence of chronic kidney disease, increased returns on investment (RoI) as a result of patent expiry of drugs, focus of government and non-profit organizations on creating awareness about anemia, research and development grants, and tax credits offered.

Based on drug type, the epoetin beta therapeutics market has been segmented into biologics and biosimilars. The biologics segment dominated the epoetin beta therapeutics market in 2016. However, epoetin beta therapeutics segment is anticipated to expand at a slow pace during the forecast period, as patents for biologic drugs have recently expired and biosimilar drugs for epoetin beta are being made available in the epoetin beta therapeutics market in a few countries. The biosimilars segment is expected to register a rapid growth rate during the forecast period, owing to the reduced cost of biosimilar drugs as compared to biologics. Based on distribution channel, the epoetin beta therapeutics market has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the epoetin beta therapeutics market in 2016 and is anticipated to remain dominant during the forecast period as well. The online pharmacy segment is anticipated to expand at a significantly high CAGR during the forecast period, owing to factors such as extending reach of online pharmacies to customers, rising availability of Internet facilities globally, and other services such as cost containment offered by online pharmacies. 

Geographically, the global epoetin beta therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global epoetin beta therapeutics market in 2016 and is anticipated to remain dominant during the forecast period also. Growth of the epoetin beta therapeutics market in the region can be attributed to the increasing number of approvals of erythropoietin drugs and incentives offered for research on chronic kidney diseases by governments in the region.

Europe is expected to follow the North America region during the forecast period. Growth of the epoetin beta therapeutics market in the Europe region can be attributed to the rising prevalence of chronic diseases in the region. The epoetin beta therapeutics market in Asia Pacific is expected to expand at the highest CAGR during the forecast period. High rate of incidence of hematological diseases in countries such as India, China, Bangladesh, and Pakistan is likely to drive the epoetin therapeutics market in Asia Pacific between 2017 and 2025.

Major players operating in the global epoetin therapeutics market include Roche, Haemato Pharm, F. Hoffmann-La Roche Ltd., and Bosnia & Herzegovina.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Epoetin Beta Therapeutics Market